Comparative efficacy of neoadjuvant therapy in the combined treatment of bladder cancer after open and transurethral resection

Authors

  • Y. V. Dumansky
  • O. V. Maltsev

DOI:

https://doi.org/10.14739/2310-1210.2013.1.15443

Keywords:

superficial bladder cancer, open and transurethral resection, combined treatment

Abstract

There are represented results of the use of different modes of neoadjuvantchemoradiation impact in the combined treatment of bladder cancer Ta-T2a stages after open and transurethral resection. The most effective was the scheme including endolymphaticpolychemotherapy which allowed in the performance of transurethral resection statistically significantly achieve 5-year survival rate and life expectancy 96,3±3,63% and 4,98±0,02 respectively.

Downloads

How to Cite

1.
Dumansky YV, Maltsev OV. Comparative efficacy of neoadjuvant therapy in the combined treatment of bladder cancer after open and transurethral resection. Zaporozhye Medical Journal [Internet]. 2013Jul.12 [cited 2025May20];15(1). Available from: https://zmj.zsmu.edu.ua/article/view/15443

Issue

No. 1 (2013): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons